Skip to content

Anixa Biosciences, Inc.: financial reference

Anixa Biosciences revenue: $210.0 thousand for the year ending 2024-10-31. Net income: -$10.9 million for the year ending 2025-10-31.

Reported financial histories

Choose a measure to inspect its definition, complete selected history and filing provenance. Each row shows the latest period available for that selected concept and original unit. Separate currencies and reporting intervals remain separate rows. Coverage dates can differ between concepts. A recent capture does not imply recent accounting coverage; these amounts are not prices.

Latest periods by selected concept and original unit
MeasurePeriod startPeriod endValueUnitFiled
Total assets-2025-10-3116,080,000USD2026-01-12
Total liabilities-2025-10-312,130,000USD2026-01-12
Stockholders equity-2025-10-3115,161,000USD2026-01-12
Cash and cash equivalents-2025-10-311,244,000USD2026-01-12
Net income or loss2024-11-012025-10-31-10,927,000USD2026-01-12
Operating cash flow2024-11-012025-10-31-7,173,000USD2026-01-12
Capital expenditure payments2019-11-012020-10-3115,791USD2022-01-04
Revenue2023-11-012024-10-31210,000USD2025-01-10
Contract revenue excluding tax2022-11-012023-10-31210,000USD2025-01-10
Financing cash flow2024-11-012025-10-312,280,000USD2026-01-12
Investing cash flow2024-11-012025-10-314,866,000USD2026-01-12
Retained earnings or deficit-2025-10-31-251,677,000USD2026-01-12
Basic weighted-average shares2024-11-012025-10-3132,454shares2026-01-12
Diluted weighted-average shares2024-11-012025-10-3132,454shares2026-01-12
Basic earnings per share2024-11-012025-10-31-0.34USD/shares2026-01-12
Diluted earnings per share2024-11-012025-10-31-0.34USD/shares2026-01-12
Net property, plant and equipment-2019-10-31200,569USD2021-01-07
Share-based compensation expense2024-11-012025-10-313,681,000USD2026-01-12
Operating income or loss2024-11-012025-10-31-11,701,000USD2026-01-12
Current assets-2025-10-3115,887,000USD2026-01-12
Interest expense2016-11-012017-10-31500,455USD2019-01-11
Current liabilities-2025-10-311,967,000USD2026-01-12
Current accounts payable-2025-10-31165,000USD2026-01-12
Net current accounts receivable-2014-10-31400,000USD2015-12-23
Selling, general and administrative expense2018-11-012019-10-315,662,828USD2020-01-09
Research and development expense2024-11-012025-10-315,071,000USD2026-01-12
Common shares outstanding-2025-10-3133,013,829shares2026-01-12
Additional paid-in capital-2025-10-31266,508,000USD2026-01-12
Total equity including noncontrolling interests-2025-10-3113,950,000USD2026-01-12
Operating lease right-of-use asset-2025-10-31193,000USD2026-01-12
Operating lease liability-2025-10-31204,000USD2026-01-12
Accumulated depreciation on property, plant and equipment-2020-10-310USD2021-01-07
Accrued current liabilities-2025-10-311,761,000USD2026-01-12
Prepaid expenses and other current assets-2025-10-31713,000USD2026-01-12
Profit or loss including noncontrolling interests2024-11-012025-10-31-11,028,000USD2026-01-12
Comprehensive income or loss2013-11-012014-10-31-9,606,314USD2015-01-29
Net income available to common stockholders2018-11-012019-10-31-11,647,054USD2020-01-09
General and administrative expense2024-11-012025-10-316,630,000USD2026-01-12
Depreciation expense2019-11-012020-10-3138,276USD2022-01-04
Amortization of intangible assets2018-11-012019-10-31418,750USD2021-01-07
Interest paid, net2021-11-012022-10-3123,000USD2023-01-04
Proceeds from issuing common stock2024-11-012025-10-312,378,000USD2026-01-12
Change in accounts receivable2019-11-012020-10-31-64,296USD2022-01-04
Change in accounts payable2024-11-012025-10-31-360,000USD2026-01-12

Filings

61 Anixa Biosciences filings with published measures: what each annual or quarterly report tagged, with the periods it covered, as reported in that filing. The histories above show the latest-filed value per period.

Inspect the source

Entity
ANIXA BIOSCIENCES, INC. / CIK 0000715446
Captured
SEC response SHA-256
e81922dde8f95b9a18ad34411c18fef0305fc9d48fc76607e8e3e2758178634a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000715446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))